The US should have vaccine safety data on high school age kids by the beginning of fall, but probably not on younger children until early next year, Dr. Anthony Fauci said Friday.
Companies are just starting tests of younger age groups but have been testing their vaccines on 12 to 17-year-olds, Fauci told a White House briefing.
“You know from Pfizer that they started off with the trial of 34,000 individuals down to 16-year-olds, and then progressed it down to 12-year-olds. So what they're going to be doing in April, starting in April, they are going to be studying 12-year-olds down to 5-to 6-year-olds,” Fauci said.
“That will take likely one year to get the information on that – likely not until the first quarter,” added Fauci, who is director of the National Institute of Allergy and Infectious Diseases, and also chief White House medical adviser.
“However, we anticipate data on high school age individuals, namely individuals 12 years old to 17 years old, by the beginning of the fall. Maybe not exactly coinciding with the first day of school, but sometime in the fall we will have that,” Fauci added.
Companies can tests their vaccines on fewer children because they have safety and efficacy data from adults, Fauci said. “So the bottom line of all of this is as follows. It is highly likely that sometime in the fall we will have data that will give us the capability of saying the safety and comparable efficacy in children 12 to 17, 18 years old,” he added.
“But then also, with the studies that I just mentioned, to getting the information to make the decision in elementary school children, almost certainly will not be firmed down until the first quarter of 2022.”
Hear more from Dr. Fauci: